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Abstract Öz 
The primary tumors, which raise isolated pancreas 
metastases are frequently of renal origin, where colorectal 
cancer, melanoma, breast and lung cancers and sarcoma 
are the following causes of metastatic pancreas cancer . In 
this article, we present a case of pancreas-metastatic renal 
cell carcinoma with its radiological features, which did not 
exert anF-18 FDG-uptake in the whole-body positron 
emission tomography (PET). 
Renal hücreli karsinom metastatik tümörler pankreas 
kanserlerinin yaklaşık %2’sini oluşturur. İzole pankreas 
metastazlarının kaynaklandıkları primer tümörler renal 
orjinli, takiben kolorektal kanser, melanom, meme, akciğer 
kanserleri, sarkomlardır. Bu makalede, PET-BT’de F18-
FDG tutulumu göstermeyen renal hücreli karsinomun  
pankreas metastazının radyolojik bulguları sunulmuştur . 
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INTRODUCTION 
Renal cell carcinoma (RCC) lesions typically 
metastasize to lung, bones, liver and brain and less 
frequently to thyroid, subcutaneous fatt issue and 
pancreas1. Metastatic tumors consist about 2% 
percent of pancreas cancers. The primary tumors, 
which raise isolated pancreas metastases are 
frequently of renal origin, where colorectal cancer, 
melanoma, breast and lung cancers and sarcoma are 
the following causes of metastatic pancreas cancer2. 
In this report, we present a case of pancreas-
metastatic renal cell carcinoma with its radiological 
features, which did not exert anF-18 FDG-uptake in 
the whole-body positronemissiontomography 
(PET).  
CASE  
A 55 years old female patient, who underwent 
nephrectomy due to a renal cell carcinoma on her 
left kidney 10 years ago, admitted to the department 
of general surgery with abdominal pain since last 
month. No pathological sign was encountered in her 
physical examination. Her laboratory findings were: 
Hb: 11,5 g/dL, AST: 39 IU/L, ALT: 23 IU/L, ALP: 
120 IU/L, Amylase: 62 U/L. In the abdominal 
USG, the pancreas can not be evaluated due to gas 
distension and no pathological USG finding was 
witnessed in the patient who underwent left 
nephrectomy. However, in the iv-oral contrast 
abdominal CT, a dilation of the pancreatic channel 
was observed which extended from tail to head of 
the pancreas with an anteroposterior diameter of 6 
mm. 
A nodularity with an approximate size of 26 mm 
featuring contrast enhancement was observed at the 
level of  the pancreatic head on the arterial phase 
images (figure 1). In the MR images, signs of 
pancreatic dilation were observed. A focal lesion 
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suspicious of malignancy was witnessed at  the 
uncinate process of the pancreas adjacent to 
duodenum, which demonstrated heterogenous 
diffusion restriction, dense contrast uptake at the 
early arterial phaseand a heterogenous signal 
intensity (figure 2). F-18 FDG PET was performed 
to the patient, who underwent a previous surgery 
due to RCC. No pathological contrast uptake was 
witnessed in the PET-CT examination (figure 3). 
Whipple operation was performed in the 
department of general surgery and the pathological 
analysis outcoma indicated an RCC metastasis.  
 
Figure 1. Nodularity demonstrating contrast uptake 
at the level of the pancreatic head during the arterial 
phase of the abdominal CT 
 
 
Figure 2. A focal lesion suspicious of malignancy at 
the uncinate process of the pancreas adjacent to 
duodenum with heterogenous diffusion restriction, 
dense contrast uptake at the early arterial phase and 
a heterogenous signal intensity. 
 
Figure 3. No pathological FDG uptake was 
detected in the PET-CT examination. 
DISCUSSION 
RCC can metastasize to pancreas via both 
haematogenous and lymphatic  routes, yet its direct 
metastatic spread to pancreas is rare. Commonly, a 
single and asymptomatic pancreas metastasis is 
observed3. The metastasis frequency is 25% percent 
at the RCC diagnosisand 40% percent during the 
disease progress. An average interval of 6 years 
could be encountered between detection of the 
primary tumor and the metastatic lesion1.  
In our case, a 10 years gap had occured between the 
pancreatic metastasis and the nephrectomy 
performed due to RCC;and the patient presented 
with abdominal pain at her recent admission. Three 
types of metastatic involvement were defined for the 
metastatic tumors of pancreas: Single localized 
nodule (50%-73%), diffuse pancreatic enlargement 
(%15-%44) and multiple pancreatic nodules (%5-
%10). In the contrast-free CT, single lesions are 
generally hypodense relative to the normal 
pancreas;and in the contrast-enhanced CT, their 
contrast uptake ocur commonly during the arterial 
phase.  
In the MRI scanning, they present as hypointense at 
the T1A and heterogenously hyperdense at the T2A 
images, respectively. If thelesion has a large size, a 
rim can be seen around the lesion at the contrast 
images. Homogenous contrast uptake generally 
occurs in small lesions4.  
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In our case, the iv-oral contrast abdominal CT 
examination revealed a prominent dilation of  the 
pancreatic channel from the pancreatic tail to head 
and a nodularity  with contrast enhancement at the 
level of the pancreatic head on the arterial phase 
images. Pancreatic dilation signs were also seen in 
MRI scanning. A focal lesion suspicious of 
malignancy was witnessed at the uncinate process of 
the pancreas adjacent to duodenum, which 
demonstrated heterogenous diffusion restriction, 
dense contrast uptake at the early arterial phase and 
a heterogenous signal intensity. Malignant cells exert 
an enhanced glucose consumption;and hence, the 
elevated glucose metabolism can be demonstrated 
via PET analysis4. Although, the PET-CT could give 
negative results in some malignancies. 
Bronchoalveolar carcinomas and carcinoid tumors 
of the lung, hepatoma, colon cancer, mucinous 
tumors of the gastrointestinal system and low-grade 
lymphnodes could be among the FDG-PET-
negative malignant lesions. Also in our case, any 
pathological FDG-uptake was not demonstrated.  
In conclusion, RCC is a malignancy, which could 
make late metastasis to organs including pancreas. It 
should be kept in mind that the FDG-PET 
resultscould be negative in primary and metastatic 
RCC lesions; and hence, CT findings shall be 
cautiously interpreted in patients with a history of 
RCC.  
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